videoSlug

VideoSlug_VideoQuery

slug

VideoPageContentQuery

content

videos

query VideoSlug_VideoQuery(
  $videoSlug: String!
) {
  ...VideoPageContentQuery_1X4EH4
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment LatestVideos_Videos on Query {
  videos(first: 5, upcoming: false, order: {field: liveTime, direction: DESC}) {
    edges {
      node {
        id
        title
        lang
        pageUrl
        liveTime
        isLive
        companies {
          name
          id
        }
      }
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment VideoPageContentQuery_1X4EH4 on Query {
  content(slug: $videoSlug, type: [VIDEO, WEBCAST]) {
    __typename
    title
    slug
    lang
    htmlBody
    ... on Video {
      imgUrl
      videoUrl
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ... on Webcast {
      imgUrl
      videoUrl
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ...ContentBasicInfo
    ...ContentMetadata
    id
  }
  ...LatestVideos_Videos
}


type

__typename

title

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

first

order

upcoming

edges

Head of Equities

Michael Friis

ExpreS2ion Biotech Holding

In connection with this month's two announcements on Malaria commercialization and reverse share split, we sat down with the company’s CEO Bent Frandsen to get more flavor on these news.

On 16 October 2024, ExpreS2ion Biotechnologies announced that the company had signed a term sheet with Serum Institute of India Private Limited (SIIPL), a leading global vaccine manufacturer, to commercialize malaria vaccines currently in Phase I and Phase II. 
On 21 October 2024, a reverse share split of the company&#x2019;s shares was resolved, whereby 40 existing shares would be consolidated into 1 share, which is effective today. 
In connection with these announcements, we sat down with the company&#x2019;s CEO Bent Frandsen to get more flavor on the news. Hear more about the potential partner on the malaria vaccines and the next steps, as well as the rationale behind carrying out a reverse share-split in the video.&#xa0;
ExpreS2ion Biotechnologies is a Danish pharmaceutical company, which focuses on the development of vaccines through the use of its non-viral Drosophila S2 cells-based expression system. Disclaimer: HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Digital IR/Corporate Visibility subscription agreement. /Michael Friis 13:53, 30 October 2024.

HC Andersen Capital

ExpreS2ion Biotechnologies – Reverse share split and malaria commercialization

Helsingin pörssin roskakori? Vieraana Iikka Numminen | inderesPodi 211

Wetteri

Wetteri Q3'24: Uusien autojen myynti historiallisen vaimeaa

Audientes

Audientes – Presentation of Q3 2024 report

Wetteri, Webcast, Q3'24

WithSecure

WithSecuren sijoittajapäivä 22.11.2024

Pysy ajantasalla Inderesin uutiskirjeillä